|
Diabetes Medication Article
Types of Insulin Delivery Devices
All insulin delivery devices inject insulin through the skin and into
the fatty tissue below.
Most people inject the insulin with a syringe that delivers insulin just
under the skin. Others use insulin pens, jet injectors, or insulin pumps.
Several new approaches for taking insulin are under development.
Insulin Pumps
Insulin pumps are small pumping devices worn outside of your body. They
connect by flexible tubing to a catheter that is located under the skin
of your abdomen. You program the pump to dispense the necessary amount
of insulin. Usually, you set the pump to give a steady small dose of insulin,
but you can give an additional amount in a short time if needed, such
as after a meal. If adjusted properly, these pumps allow close control
of your insulin levels without multiple injections. You should not use
this type of pump during physical activities that may damage the pump
or disrupt the pump's connection to the body. You still need to monitor
your blood glucose levels regularly if you use this type of device.
Diabetes Testing Center
Heart News Center
Hot Home Gym Reviews
The Secret Wisdom You Have Inside
Get Rid of Your Belly fat
Humulin R Insulin News
Humulin R insulin
IMPORTANT: Bing News RSS feed has moved!
The company opened Erl Wood, its first R&D site outside the US ... Eli Lilly's current products include Prozac and Humulin human insulin. "One of the major factors in our decision to base the research site where we are is the UK's world class ...
Read moreLord Winston opens £5.4m Eli Lilly building at Windlesham
Global sales of Alimta, the company's lung cancer drug, rose 5 percent to $607 million. Its Humalog insulin rose 12 percent to $590 million, while its Humulin insulin brand grew 6 percent to $308 million. The company slightly raised its 2012 profit ...
Read moreLilly quarterly sales, profit beats forecasts
The European Commission granted marketing authorization to Byetta® (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin ... as well as the expiration of the R&D tax credit in the U.S. at the end of ...
Read moreLilly Quarterly Profit Slips
The European Commission granted marketing authorization to Byetta (exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin ... as well as the expiration of the R&D tax credit in the U.S. at the end of 2011.
Read more